UBS ETF Please confirm you are resident in Italy to proceed.

In addition to the usual risks referring to market fluctuations, securities and index type, the investor has to be aware that the funds detailed in this document are also exposed to other risks, such as: secondary market negotiations, differences between NAV and market prices, calculation changes, differences in publications of the index on behalf of the index provider, risks connected to the listing of the index components on different markets, risks connected to the use of derivatives.

There are also further risks these funds that replicate equity or bond indexes are exposed to. The investor is therefore required to have an adequate tolerance and capacity to bear such risks.

For a complete analysis of all the risks described we recommend to read carefully the prospectus.

Back

UBS ETF (LU) Bloomberg Barclays US Liquid Corporates UCITS ETF (USD) A-dis

Net asset value 18.0938 USD

Last update

26.02.2020

ISIN: LU1048316647

Asset Class:  Fixed Income

Download all data as XLS File

10 largest constituents

#

Securities

Coupon

Maturity

ISIN

Currency

Price

Weight %

1

CVS HEALTH CORP 4.30000% 18-25.03.28

4.30

25.03.2028

US126650CX62

USD

111.55

1.33

2

CVS HEALTH CORP 5.05000% 18-25.03.48

5.05

25.03.2048

US126650CZ11

USD

123.18

1.30

3

ABBVIE INC-144A 4.25000% 19-21.11.49

4.25

21.11.2049

US00287YBS72

USD

112.10

0.85

4

CVS HEALTH CORP 3.70000% 18-09.03.23

3.70

09.03.2023

US126650CV07

USD

105.27

0.84

5

CVS HEALTH CORP 4.78000% 18-25.03.38

4.78

25.03.2038

US126650CY46

USD

118.24

0.78

6

ABBVIE INC-144A 3.20000% 19-21.11.29

3.20

21.11.2029

US00287YBW84

USD

105.01

0.77

7

CVS HEALTH CORP 4.10000% 18-25.03.25

4.10

25.03.2025

US126650CW89

USD

109.40

0.72

8

COMCAST CORP 4.70000% 18-15.10.48

4.70

15.10.2048

US20030NCM11

USD

130.30

0.70

9

VERIZON COMMUNICATIONS INC 4.32900% 18-21.09.28

4.33

21.09.2028

US92343VER15

USD

116.56

0.66

10

BRISTOL-MYERS SQUIBB CO-144A 4.25000% 19-26.10.49

4.25

26.10.2049

US110122CD86

USD

126.89

0.62

This overview shows the portfolio positions. The actual positions of the ETF may deviate from this. Source: State Street, 25.02.2020

Composition data

Ticker

CBUS SW

Total net assets

383,727,115.17

Total outstanding ETF Shares

21,211,139.00

Base currency

USD

Source: State Street, 27.02.2020

Disclaimer

For marketing and information purposes by UBS. UBS funds under Luxembourg law. Representative in Italy for UBS funds, UBS Asset Management (Italia) SGR S.p.A., Via della Spiga, 30 Milano. The prospectus, the simplified prospectus or Key investor information, the fund regulations, as well as the Articles of Association for UBS SICAVs and the latest annual or semi-annual report may be obtained free of charge from UBS Asset Management (Italia) SGR S.p.A., Via della Spiga, 30 Milano. Barclays US Liquid Corporates UCITS, Barclays Euro Area Liquid Corporate 1-5 Year Index, Barclays US Liquid Corporate 1-5 Year Index and Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index (the “Barclays Indices”) are trademarks of Barclays Capital or its affiliates and have been licensed for use in connection with UBS Exchange Traded Funds. UBS Exchange Traded Funds based on Barclays Indices are not sponsored or endorsed by Barclays Capital or its affiliates. Neither Barclays Capital nor its affiliates make any representation regarding the advisability of investing in UBS Exchange Traded Funds. Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/glossary. © UBS 2020. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.